GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
29.53
-0.74 (-2.44%)
At close: Aug 10, 2026, 4:00 PM EDT
29.94
+0.41 (1.39%)
After-hours: Aug 10, 2026, 6:30 PM EDT
GH Research Earnings Call Transcripts
Fiscal Year 2025
-
GH001 showed rapid, robust, and sustained efficacy in TRD, with a high remission rate and favorable safety profile. Long-term data indicate durable remission with infrequent treatments and fewer clinic visits compared to current standards.